Timea Pocza

Budapest, BU, Hungary

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Systemic immune activation in hereditary cancer predisposition syndromes: a cross-sectional study.

Systemic immune activation in hereditary cancer predisposition syndromes: a cross-sectional study.

Journal: BMC medicine

Published: March 11, 2026

Processed Transcript Insertion as a Novel Germline Mutational Mechanism in BRCA1-Associated Hereditary Breast Cancer.

Processed Transcript Insertion as a Novel Germline Mutational Mechanism in BRCA1-Associated Hereditary Breast Cancer.

Journal: Cancers

Published: November 03, 2025

Double Pathogenic or Likely Pathogenic Variants in Cancer Predisposition Genes in Hungarian Cancer Patients.

Double Pathogenic or Likely Pathogenic Variants in Cancer Predisposition Genes in Hungarian Cancer Patients.

Journal: International journal of molecular sciences

Published: August 07, 2025

Comprehensive analysis of germline and somatic SDHA alterations reveals rare incidental germline variants and prognostic implications of somatic loss in breast cancer.

Comprehensive analysis of germline and somatic SDHA alterations reveals rare incidental germline variants and prognostic implications of somatic loss in breast cancer.

Journal: Endocrine-related cancer

Published: August 04, 2025

Pathogenic large duplication in TP53 as a hereditary predisposing factor in breast cancer

Pathogenic large duplication in TP53 as a hereditary predisposing factor in breast cancer

Journal: Magyar onkologia

Published: November 11, 2024

Comprehensive Clinical Genetics, Molecular and Pathological Evaluation Efficiently Assist Diagnostics and Therapy Selection in Breast Cancer Patients with Hereditary Genetic Background.

Comprehensive Clinical Genetics, Molecular and Pathological Evaluation Efficiently Assist Diagnostics and Therapy Selection in Breast Cancer Patients with Hereditary Genetic Background.

Journal: International journal of molecular sciences

Published: November 04, 2024

Pathogenic role of CHEK2 variants in Hungarian cancer patients: implications for breast cancer risk and genetic counselling

Pathogenic role of CHEK2 variants in Hungarian cancer patients: implications for breast cancer risk and genetic counselling

Journal: Magyar onkologia

Published: August 29, 2024

Spectrum and genotyping strategies of "dark" genetic matter in germline susceptibility genes of tumor syndromes.

Spectrum and genotyping strategies of "dark" genetic matter in germline susceptibility genes of tumor syndromes.

Journal: Critical reviews in oncology/hematology

Published: August 22, 2024

Whole genome sequencing completes the molecular genetic testing workflow of patients with Lynch syndrome.

Whole genome sequencing completes the molecular genetic testing workflow of patients with Lynch syndrome.

Journal: NPJ genomic medicine

Published: May 10, 2024

Cost-effectiveness of Genetic Testing of Endocrine Tumor Patients Using a Comprehensive Hereditary Cancer Gene Panel.

Cost-effectiveness of Genetic Testing of Endocrine Tumor Patients Using a Comprehensive Hereditary Cancer Gene Panel.

Journal: The Journal of clinical endocrinology and metabolism

Published: February 08, 2024

PALB2 Variants Extend the Mutational Profile of Hungarian Patients with Breast and Ovarian Cancer.

PALB2 Variants Extend the Mutational Profile of Hungarian Patients with Breast and Ovarian Cancer.

Journal: Cancers

Published: July 26, 2023

A common genetic variation in GZMB may associate with cancer risk in patients with Lynch syndrome.

A common genetic variation in GZMB may associate with cancer risk in patients with Lynch syndrome.

Journal: Frontiers in oncology

Published: July 28, 2022

Showing 1-12 of 25

Last Updated: 09/26/2026